Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.56
-$1.37 (-5.28%)
After-hours:
Nov 5, 2026, 6:19 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1M | n/a | 10M | 15M | 15M | 15M | 5M | n/a | 50M | 50M | 50M | 50M | n/a | n/a | n/a |
Cost of Revenue | 60.73M | 103.75M | 103.75M | 48.03M | 76.56M | 67.34M | 89.98M | 110.4M | 76.87M | 43.06M | 35.77M | 31.32M | 31.32M | 31.32M | 15.97M |
Gross Profit | -59.73M | -103.75M | -93.75M | -33.03M | -61.56M | -52.34M | -84.98M | -110.4M | -26.87M | 6.94M | 14.24M | 18.68M | -31.32M | -31.32M | -15.97M |
Operating Income | -475.57M | -423.08M | -383.06M | -200.7M | -189.1M | -173.64M | -163.89M | -133.04M | -56.44M | -45.64M | -37.15M | -31.36M | -66.98M | -38.08M | -18.99M |
Interest Income | 9.62M | 3.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -484.16M | -425.03M | -377.82M | -189.66M | -176.76M | -162.54M | -156.56M | -128.67M | -54.46M | -45.53M | -36.82M | -31.53M | -67.14M | -38.09M | -18.99M |
Net Income | -484.38M | -425.15M | -377.74M | -189.9M | -177.01M | -162.76M | -156.99M | -128.97M | -54.76M | -45.83M | -37.12M | -31.53M | -67.14M | -38.09M | -18.99M |
Selling & General & Admin | 61.42M | 57.81M | 53.32M | 49.2M | 43.47M | 37.23M | 29.75M | 22.64M | 20.21M | 18.31M | 17.11M | 15.98M | 10.95M | 6.96M | 3.22M |
Research & Development | 380.15M | 360.26M | 334.74M | 161.5M | 160.63M | 151.41M | 139.14M | 110.4M | 86.22M | 67.33M | 60.03M | 55.38M | 46.03M | 31.11M | 15.77M |
Other Expenses | -25.72M | -98.75M | -98.75M | -43.03M | -76.56M | -67.34M | -89.98M | -110.4M | -76.87M | -33.06M | -25.77M | -21.32M | -21.32M | -31.32M | -15.97M |
Operating Expenses | 415.85M | 319.32M | 289.31M | 167.67M | 127.54M | 121.3M | 78.91M | 22.64M | 29.57M | 52.58M | 51.38M | 50.04M | 35.66M | 6.76M | 3.02M |
Interest Expense | 16.93M | 6.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -1.49M | -691K | -691K | 803K | 1M | 743K | 743K | 943K | 743K | 200K | 200K | 700K | 700K | 700K | 700K |
Cost & Expenses | 476.57M | 423.08M | 393.06M | 215.7M | 204.1M | 188.64M | 168.89M | 133.04M | 106.44M | 95.64M | 87.15M | 81.36M | 66.98M | 38.08M | 18.99M |
Income Tax Expense | 220K | 126K | -79K | 244K | 244K | 224K | 429K | 301K | 301K | 301K | 301K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.11M | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
Shares Outstanding (Diluted) | 63.11M | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M | 38.32M | 38.32M | 38.32M |
EPS (Basic) | -9.62 | -9.10 | -8.44 | -4.53 | -4.23 | -3.97 | -3.90 | -3.28 | -2.15 | -1.92 | -1.69 | -1.55 | -1.76 | -1 | -0.50 |
EPS (Diluted) | -9.62 | -9.10 | -8.44 | -4.53 | -4.23 | -3.97 | -3.90 | -3.28 | -2.15 | -1.92 | -1.69 | -1.55 | -1.76 | -1 | -0.50 |
EBITDA | -457.28M | -408.44M | -367.84M | -189.58M | -176.66M | -162.41M | -156.42M | -128.54M | -54.33M | -35.27M | -26.57M | -21.28M | -56.91M | -38.04M | -18.97M |
EBIT | -457.31M | -408.47M | -367.9M | -189.66M | -176.76M | -162.54M | -156.56M | -128.67M | -54.46M | -35.38M | -26.68M | -21.39M | -57M | -38.09M | -18.99M |
Depreciation & Amortization | 31K | 39K | 56K | 79K | 104K | 127K | 137K | 134K | 124K | 118K | 113K | 108K | 82K | 53K | 25K |
Add to Watchlist
Select watchlists to add or remove ZBIO